An Open Label Study to Assess the Effect of Euryco-10® Oral Dietary Supplement in Senior Men

NCT04584918 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2020-10-14

No results posted yet for this study

Summary

To evaluate the effect and support the tolerance of orally ingested formulation containing Eurycoma longifolia dietary supplement (Euryco-10) on a cohort of senior men.

Conditions

  • Healthy Aging

Sponsors & Collaborators

  • Innovus Pharmaceuticals, Inc.

    lead INDUSTRY

Eligibility

Min Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-31
Primary Completion
2021-01-31
Completion
2021-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04584918 on ClinicalTrials.gov